VI BANH: Open Payments
NPI 1154897882 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,535 in 162 payments from 17 companies in 2025. Trend: 2023 $2,233 · 2024 $3,974 · 2025 $3,535
Food & beverage: $3,130Consulting: $375Travel & lodging: $25Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $941 |
| Janssen Biotech, Inc. | 46 | $925 |
| UCB, Inc. | 17 | $361 |
| Amgen Inc. | 7 | $218 |
| Galderma Laboratories, L.P. | 14 | $209 |
| Regeneron Healthcare Solutions, Inc. | 9 | $186 |
| GENZYME CORPORATION | 5 | $181 |
| Novartis Pharmaceuticals Corporation | 9 | $161 |
| Lilly USA, LLC | 3 | $60 |
| KYOWA KIRIN, INC. | 2 | $48 |
Products named: TREMFYA, BOTOX, Bimzelx, SKYRIZI, DUPIXENT, OTEZLA, RINVOQ, NEMLUVIO.
Industry payments across DE — which companies pay providers there.
